Clinical trial · Interventional
Acupuncture for Lung Cancer-Related Fatigue
The Effects of Acupuncture for Lung Cancer-Related Fatigue, a Clinical Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate the efficacy and safety of acupuncture in alleviating cancer-related fatigue (CRF) among lung cancer survivors. It addresses the key issue of limited high-quality evidence for acupuncture's effect on CRF by rigorously comparing real acupuncture against a non-penetrating sham needle control in 120 eligible participants. Patients will be centrally randomized (1:1), blinded, and receive 12-session treatment over 4 weeks. Participants will complete treatment and attend follow-up visits up to week 16, and repeatedly complete fatigue (BFI-C, MFI-20), psychological (PHQ-9, GAD-7, FCRI), functional (CWSAS), and sleep (ISI) assessments.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupuncture | Device | — | UNRESOLVED |
| Sham Comparator | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Acupuncture
- interventionNames
- Device: Acupuncture
- type
- SHAM_COMPARATOR
- label
- sham acupuncture
- interventionNames
- Device: Sham Comparator
Primary outcomes (1)
- measure
- The proportion of patients whose score of average fatigue over the past 24 hours decreased by at least 2 points on the Brief Fatigue Inventory-Chinese (BFI-C) compared to baseline.
- timeFrame
- At the 4th week.
- description
- The severity of fatigue is scored on a scale from 0 to 10, higher scores indicating more severe fatigue.
Secondary outcomes (15)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a history of lung cancer who have completed initial treatment (including surgery, radiotherapy, and/or chemotherapy) at least 8 weeks prior; * Aged between 18 and 75 years; * Meet the diagnostic criteria for cancer-related fatigue; * Estimated to have a survival period of at least 3 months; * Patients with moderate to severe cancer-related fatigue (the highest fatigue score in the past 24 hours on the Chinese version of the Brief Fatigue Inventory \[BFI-C\] ≥ 4 points); * ECOG Performance Status score ranges from 0 to 2 points * Voluntarily join this study and sign the informed consent form. Exclusion Criteria: * Patients experiencing significant fatigue symptoms before being diagnosed with lung cancer; * Patients with severe anxiety and depression; * Patients showing notable cognitive impairment or suicidal tendencies; * Patients with a history of hypothyroidism or chronic fatigue syndrome; * Patients suffering from moderate to severe anemia, with hemoglobin levels below 90 g/L; * Patients experiencing severe pain, with a Numeric Rating Scale (NRS) score of 7 or higher; * Patients with serious sleep disorders; * Patients with severe malnutrition; * Patients with seriously diminished physical function; * Patients who have undergone acupuncture treatment for cancer-related fatigue within the past month; * Patients with uncontrolled severe underlying conditions, such as heart failure, myocardial infarction, unstable angina, endocrine disorders, gastrointestinal issues, neurological impairments, severe infections, liver and kidney failure, or chronic obstructive pulmonary disease; * Patients with poor adherence; * Patients who are breastfeeding, pregnant, or planning to conceive within the next four months.
References
Publications (0)
Data not yet available